Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) Rallies 60% After Releasing Positive Phase 2 Clinical Trials Data on Treatment of Acute Schizophrenia
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is engaged as a clinical-stage biopharmaceutical company that primarily focuses on the research, development, ...
